Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 6, 2010, Pages 535-540

  Chu, Chia Ming ^a   Chen, Yi Cheng ^a   Tai, Dar In ^a   Liaw, Yun Fan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Chronic Hepatitis B; Sex; Viral Genotype; Viral Load; Viral Mutants

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS E ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROMOTER REGION; RISK FACTOR; SEX DIFFERENCE; VIRUS CARRIER; VIRUS LOAD; VIRUS TYPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CARRIER STATE; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 77952745777     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.03.006     Document Type: Article

References (28)

1. Liaw Y.F., and Chu C.M. Hepatitis B virus infection. Lancet 373 (2009) 582-592
2. Hsu Y.S., Chien R.N., Yeh C.T., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002) 1522-1527
3. Chu C.M., Hung S.J., Lin J., et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 116 (2004) 829-834
4. Feld J.J., Ayers M., El-Ashry D., et al. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 46 (2007) 1057-1070
5. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
6. Liaw Y.F., Leung N., Kao J.H., et al. Asian-Pacific consensus statement on management of chronic hepatitis B: a 2008 update. Hepatol Int 2 (2008) 263-283
7. EASL. Clinical practice guidelines: management of chronic hepatitis B. European Association For The Study Of The Liver. J Hepatol 50 (2009) 227-242
8. Gish R.G., and Locarnini S.A. Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol 4 (2006) 666-676
9. Keeffe E.B., Dieterich D.T., Han S.H., et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6 (2008) 1315-1341
10. Chu C.J., Hussain M., and Lok A.S. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36 (2002) 1408-1415
11. Manesis E.K., Papatheodoridis G.V., Sevastianos V., et al. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98 (2003) 2261-2267
12. Lin C.L., Liao L.Y., Liu C.J., et al. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 45 (2007) 1193-1198
13. Kumar M., Sarin S.K., Hissar S., et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134 (2008) 1376-1384
14. Chu C.M., and Liaw Y.F. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 104 (2009) 1693-1699
15. Papatheodoridis G.V., Chrysanthos N., Hadziyannis E., et al. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 15 (2008) 434-441
16. Tai D.I., Lin S.M., Sheen I.S., et al. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 49 (2009) 1859-1867
17. Chu C.M., and Liaw Y.F. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow up. Hepatology 45 (2007) 1187-1192
18. Lin D.Y., Sheen I.S., Chiu C.T., et al. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 21 (1993) 303-308
19. Chu C.M., and Liaw Y.F. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol 43 (2005) 411-417
20. Chu C.M., Yeh C.T., Lee C.S., et al. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol 40 (2002) 16-21
21. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002) 1-10
22. Chu C.M., and Liaw Y.F. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 133 (2007) 1458-1465
23. Kumar M., Chauhan R., Gupta N., et al. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients. Gastroenterology 136 (2009) 1272-1280
24. Martinot-Peignoux M., Boyer N., Colombat M., et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36 (2002) 543-546
25. Papatheodoridis G.V., Manesis E.K., Manolakopoulos S., et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?. Hepatology 48 (2008) 1451-1459
26. Baptista M., Kramvis A., and Kew M.C. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29 (1999) 946-953
27. Kao J.H., Chen P.J., Lai M.Y., et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003) 327-334
28. Lai C.L., and Yuen M.F. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med 147 (2007) 58-61